Skip to main content

Other Grants Program

What it is.

Through special collaborations with other organizations we can advance research in areas of high unmet need. Our Screen to Lead program funds science focused on medicinal chemistry and/or drug target screening.

What it does.

LLS has significant collaborations with organizations, including The Snowdome Foundation, The Rising Tide Foundation for Clinical Cancer Research (RTFCCR), The Babich Family Foundation, The MPN Research Foundation; The International Waldenstrom’s Macroglobulinemia Foundation (IWMF); The Hairy Cell Leukemia Foundation and The Sass Foundation for Medical Research.

The Screen to Lead program addresses the significant need for resources to develop small molecules into drug-like compounds suitable for preclinical proof-of-concept testing in cancer models. The grants also support their efforts to identify molecular targets suitable for therapy.

FY20 Grant Recipients

Screen to Lead Program:

Jolanta Grembecka, PhD
University of Michigan Rogel Cancer Center
Screening for inhibitors of ASH1L as a new treatment for Acute Myeloid Leukemia

John Sondek, PhD
The University of North Carolina at Chapel Hill
PLC-gamma isozymes: unexploited drug targets for the treatment of leukemias and lymphomas

Special Collaborations:

Coming Soon!